Remark Media (MARK) Minority Investment May Be Worth $4.30/sh - Roth Roth Capital analyst Darren Aftahi reiterated a Buy rating and $7.50 price target on Remark Media (NASDAQ: MARK) after Privately-held Sharecare announced Quest Diagnostics (DGX-NC) as its preferred laboratory partner. Quest is also making a strategic investment in the company that MARK has a meaningful investment in. The analyst estimates that MARK owns ~4.5% of Sharecare and this announcement signals upcoming monetization.
The analyst stated "We believe this could set the stage for a potential IPO going forward. Based on our current analysis, we believe MARK’s stake is worth ~$150-$175M, implying ~$3.65-$4.31/share, multiples of its current ~$43M value. A liquidity event in Sharecare would help to much better capitalize MARK’s AI business".